Network pharmacology: curing causal mechanisms instead of treating symptoms
For complex diseases, most drugs are highly ineffective, and the success rate of drug
discovery is in constant decline. While low quality, reproducibility issues, and translational …
discovery is in constant decline. While low quality, reproducibility issues, and translational …
Small molecule metabolites: discovery of biomarkers and therapeutic targets
S Qiu, Y Cai, H Yao, C Lin, Y Xie, S Tang… - Signal Transduction and …, 2023 - nature.com
Metabolic abnormalities lead to the dysfunction of metabolic pathways and metabolite
accumulation or deficiency which is well-recognized hallmarks of diseases. Metabolite …
accumulation or deficiency which is well-recognized hallmarks of diseases. Metabolite …
Phenotypic drug discovery: recent successes, lessons learned and new directions
F Vincent, A Nueda, J Lee, M Schenone… - Nature Reviews Drug …, 2022 - nature.com
Many drugs, or their antecedents, were discovered through observation of their effects on
normal or disease physiology. For the past generation, this phenotypic drug discovery …
normal or disease physiology. For the past generation, this phenotypic drug discovery …
Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis
X Li, S Wei, S Niu, X Ma, H Li, M Jing, Y Zhao - Computers in biology and …, 2022 - Elsevier
Abstract Background Huanglian Jiedu Decoction (HLJDD) is a classical herbal formula with
potential efficacy in the treatment of sepsis. However, the main components and potential …
potential efficacy in the treatment of sepsis. However, the main components and potential …
Network pharmacology approach for medicinal plants: review and assessment
Natural products have played a critical role in medicine due to their ability to bind and
modulate cellular targets involved in disease. Medicinal plants hold a variety of bioactive …
modulate cellular targets involved in disease. Medicinal plants hold a variety of bioactive …
US FDA approved drugs from 2015–June 2020: a perspective
In the present work, we report compilation and analysis of 245 drugs, including small and
macromolecules approved by the US FDA from 2015 until June 2020. Nearly 29% of the …
macromolecules approved by the US FDA from 2015 until June 2020. Nearly 29% of the …
TCM network pharmacology: a new trend towards combining computational, experimental and clinical approaches
W Xin, W Zi-Yi, JH Zheng, LI Shao - Chinese journal of natural medicines, 2021 - Elsevier
Traditional Chinese medicine (TCM) is a precious treasure of the Chinese nation and has
unique advantages in the prevention and treatment of diseases. The holistic view of TCM …
unique advantages in the prevention and treatment of diseases. The holistic view of TCM …
Advancing the use of genome-wide association studies for drug repurposing
Genome-wide association studies (GWAS) have revealed important biological insights into
complex diseases, which are broadly expected to lead to the identification of new drug …
complex diseases, which are broadly expected to lead to the identification of new drug …
[PDF][PDF] Preliminary exploration of the mechanism of Qingfei Paidu decoction against novel coronavirus pneumonia based on network pharmacology and molecular …
H Wu, JQ Wang, YW Yang, TY Li, YJ Cao… - Acta Pharmaceutica …, 2020 - elotus.org
ㅹ: ส Ҿ 㖁㔌㦟⨶ ᆖ઼࠶ ᆀሩ᧕ᢰᵟࡍ↕ ᧒㍒ Ā 㛪ᧂ∂⊔ āᣇᯠරߐ⣦⯵∂ 㛪⚾⭘ ᵪࡦ were
applied to explore the mechanism of anti-coronavirus pneumonia (coronavirus disease …
applied to explore the mechanism of anti-coronavirus pneumonia (coronavirus disease …
Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics
Abstract Knowledge of therapeutic targets and early drug candidates is useful for improved
drug discovery. In particular, information about target regulators and the patented …
drug discovery. In particular, information about target regulators and the patented …